[Why antiretroviral therapy must not begin to early?]

Rev Prat. 2004 Apr 30;54(8):819-24.
[Article in French]
No abstract available

MeSH terms

  • Acquired Immunodeficiency Syndrome / prevention & control
  • Anti-HIV Agents / adverse effects
  • Anti-HIV Agents / therapeutic use*
  • CD4 Lymphocyte Count
  • Disease Progression
  • Glycolipids / metabolism
  • HIV Infections / blood
  • HIV Infections / drug therapy*
  • HIV Infections / physiopathology
  • HIV-Associated Lipodystrophy Syndrome / etiology
  • Humans
  • Mitochondrial Diseases / chemically induced
  • Time Factors
  • Viral Load

Substances

  • Anti-HIV Agents
  • Glycolipids